Menu
GeneBe

SHARPIN

SHANK associated RH domain interactor, the group of Linear ubiquitin chain assembly complex |Zinc fingers RANBP2-type

Basic information

Region (hg38): 8:144098632-144108124

Links

ENSG00000179526NCBI:81858OMIM:611885HGNC:25321Uniprot:Q9H0F6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SHARPIN gene.

  • Inborn genetic diseases (25 variants)
  • not provided (4 variants)
  • not specified (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SHARPIN gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
25
clinvar
1
clinvar
3
clinvar
29
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
2
clinvar
2
Total 0 0 25 1 6

Variants in SHARPIN

This is a list of pathogenic ClinVar variants found in the SHARPIN region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-144098945-G-C not specified Uncertain significance (May 24, 2023)2551210
8-144098948-C-T Benign (Apr 02, 2018)710592
8-144098981-C-T not specified Uncertain significance (Feb 15, 2023)2466884
8-144099086-G-A not specified Uncertain significance (Dec 19, 2022)2336658
8-144099167-C-T not specified Uncertain significance (Nov 21, 2023)3161563
8-144099183-G-C not specified Uncertain significance (Dec 04, 2023)3161562
8-144099283-C-A not specified Uncertain significance (Nov 17, 2022)2327057
8-144099319-G-A not specified Benign (Mar 29, 2016)403432
8-144099357-C-T not specified Uncertain significance (Aug 16, 2022)2307203
8-144099393-C-T not specified Uncertain significance (Dec 14, 2022)2335018
8-144099535-C-T not specified Uncertain significance (Nov 15, 2021)2261782
8-144099544-T-C not specified Uncertain significance (Mar 24, 2023)2523106
8-144099585-G-A not specified Likely benign (Dec 11, 2023)3161561
8-144099719-G-A not specified Uncertain significance (Aug 04, 2021)2241297
8-144099724-C-G not specified Uncertain significance (Jul 21, 2022)2302962
8-144099747-CAG-C AUTOINFLAMMATION WITH EPISODIC FEVER AND IMMUNE DYSREGULATION Pathogenic (Apr 25, 2024)3233310
8-144099755-C-T not specified Uncertain significance (Oct 26, 2022)2319742
8-144099785-G-C not specified Uncertain significance (Apr 13, 2023)2536704
8-144099794-C-G not specified Uncertain significance (Mar 14, 2023)2471925
8-144099812-C-G not specified Uncertain significance (Jan 23, 2024)3161559
8-144099812-C-T not specified Uncertain significance (Feb 01, 2023)2480399
8-144099820-C-T not specified Likely benign (Dec 12, 2023)3161558
8-144099821-G-A not specified Uncertain significance (Feb 27, 2024)3161557
8-144099920-C-A Benign (Apr 02, 2018)711023
8-144099933-C-G not specified Uncertain significance (Jan 26, 2022)2272600

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SHARPINprotein_codingprotein_codingENST00000398712 89492
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00002310.9191247800161247960.0000641
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.04392152131.010.00001182361
Missense in Polyphen5361.2390.86546701
Synonymous-1.9211692.51.250.00000549871
Loss of Function1.631017.30.5778.17e-7184

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001310.000131
Ashkenazi Jewish0.00009980.0000993
East Asian0.0001110.000111
Finnish0.000.00
European (Non-Finnish)0.00006260.0000618
Middle Eastern0.0001110.000111
South Asian0.0001040.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the LUBAC complex which conjugates linear polyubiquitin chains in a head-to-tail manner to substrates and plays a key role in NF-kappa-B activation and regulation of inflammation. LUBAC conjugates linear polyubiquitin to IKBKG and RIPK1 and is involved in activation of the canonical NF-kappa-B and the JNK signaling pathways. Linear ubiquitination mediated by the LUBAC complex interferes with TNF-induced cell death and thereby prevents inflammation. LUBAC is recruited to the TNF-R1 signaling complex (TNF-RSC) following polyubiquitination of TNF- RSC components by BIRC2 and/or BIRC3 and to conjugate linear polyubiquitin to IKBKG and possibly other components contributing to the stability of the complex. Together with OTULIN, the LUBAC complex regulates the canonical Wnt signaling during angiogenesis. {ECO:0000269|PubMed:21455173, ECO:0000269|PubMed:21455180, ECO:0000269|PubMed:21455181}.;
Pathway
Necroptosis - Homo sapiens (human);NOD-like receptor signaling pathway - Homo sapiens (human);Signal Transduction;Neuronal System;TNFR1-induced NFkappaB signaling pathway;TNF signaling;Death Receptor Signalling;Regulation of TNFR1 signaling;Neurexins and neuroligins;Protein-protein interactions at synapses (Consensus)

Recessive Scores

pRec
0.0834

Intolerance Scores

loftool
0.359
rvis_EVS
0.11
rvis_percentile_EVS
61.91

Haploinsufficiency Scores

pHI
0.0677
hipred
N
hipred_score
0.432
ghis
0.390

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.922

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sharpin
Phenotype
digestive/alimentary phenotype; vision/eye phenotype; immune system phenotype; skeleton phenotype; respiratory system phenotype; liver/biliary system phenotype; reproductive system phenotype; normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;

Gene ontology

Biological process
mitochondrion organization;I-kappaB kinase/NF-kappaB signaling;brain development;regulation of tumor necrosis factor-mediated signaling pathway;apoptotic nuclear changes;keratinization;positive regulation of I-kappaB kinase/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;negative regulation of inflammatory response;protein homooligomerization;protein linear polyubiquitination;regulation of CD40 signaling pathway
Cellular component
cytosol;postsynaptic density;cell junction;dendrite;LUBAC complex
Molecular function
ubiquitin-protein transferase activity;protein binding;polyubiquitin modification-dependent protein binding;identical protein binding;ubiquitin binding;protein-containing complex binding;metal ion binding